AFT PHARMACEUTICALS LIMITED (AFP)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

AFP - AFT PHARMACEUTICALS LIMITED

Year End: March
GICS Industry Group : Pharmaceuticals, Biotechnology & Life Sciences
Debt/EBITDA: 1.82
Index:

LAST PRICE CHANGE +/- CHANGE % VOLUME

$3.21

21 Feb
2024

0.000

OPEN

$3.21

0.000

HIGH

$3.21

143

LOW

$3.21

OTHER COMPANIES IN THE SAME SECTOR
1AD . ACR . ACW . ADO . AGH . ARX . AVH . BIO . BOT . CSL . CUV . EOF . GSS . HXL . IDT . IMM . IMU . IVX . LGP . MAP . MDC . MSB . MVP . MXC . MYX . NEU . NXS . OCC . OPT . OSL . PAR . PBP . PER . PNV . PYC . RAC . RCE . SPL . TLX . TRP . VIT . ZNO .
FNARENA'S MARKET CONSENSUS FORECASTS

- No Record -

Last ex-div: 16/06 - (franking ex-di

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201820192020202120222023
EPS Basic xxxxxxxxxxxxxxx9.3
DPS All xxxxxxxxxxxxxxx1.0
Sales/Revenue xxxxxxxxxxxxxxx142.7 M
Book Value Per Share xxxxxxxxxxxxxxx65.3
Net Operating Cash Flow xxxxxxxxxxxxxxx8.2 M
Net Profit Margin xxxxxxxxxxxxxxx6.80 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201820192020202120222023
Return on Capital Employed xxxxxxxxxxxxxxx16.04 %
Return on Invested Capital xxxxxxxxxxxxxxx10.38 %
Return on Assets xxxxxxxxxxxxxxx7.73 %
Return on Equity xxxxxxxxxxxxxxx16.04 %
Return on Total Capital xxxxxxxxxxxxxxx18.47 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx8.0 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201820192020202120222023
Short-Term Debt xxxxxxxxxxxxxxx3 M
Long Term Debt xxxxxxxxxxxxxxx33 M
Total Debt xxxxxxxxxxxxxxx36 M
Goodwill - Gross xxxxxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxxxxx5 M
Price To Book Value xxxxxxxxxxxxxxx4.95

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201820192020202120222023
Capex xxxxxxxxxxxxxxx8.4 M
Capex % of Sales xxxxxxxxxxxxxxx5.86 %
Cost of Goods Sold xxxxxxxxxxxxxxx76 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx49 M
Research & Development xxxxxxxxxxxxxxx5 M
Investments - Total xxxxxxxxxxxxxxx-

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

0
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

AFP STOCK CHART